Kanuma

Active Ingredient(s): Sebelipase Alfa
FDA Approved: * December 8, 2015
Pharm Company: * ALEXION PHARM

Sebelipase alfa, sold under the brand name Kanuma, is a recombinant form of the enzyme lysosomal acid lipase (LAL) that is used as a medication for the treatment of lysosomal acid lipase deficiency (LAL-D).[3][4] It is administered via intraveneous infusion.[2] It was approved for medical use in the European Union and in the United States in 2015.[5][3][2][4] Contents 1 Medical ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Kanuma 2 mg/ml Intravenous Injection, Solution, Concentrate

NDC: 25682-007

Labeler:

Alexion Pharmaceuticals, Inc.